You are viewing the site in preview mode
Skip to main content
OR −95% CI OR 95% CI OR p -valueGini coefficient CHA2 DS2 -VASc score 1.51 1.07 2.12 0.02 0.38 Age (years) 1.07 1.00 1.12 0.06 0.37 BSA (m2 ) 0.03 0.001 1.01 0.05 0.37 Chronic kidney disease 3.63 1.14 11.5 0.03 0.31 NYHA class 0.31 II 0.50 0.12 2.18 0.36 III 0.79 0.31 2.01 0.61 IV 2.52 0.98 6.47 0.05 Heart rate (bpm) 0.95 0.91 1.01 0.08 0.28 ACE-I or ARB 0.32 0.1 1.02 0.05 0.26 Diabetes 2.75 0.88 8.56 0.08 0.23 Ischaemic HF etiology 2.29 0.73 7.16 0.16 0.2 History of stroke or TIA 4.00 0.80 20.1 0.09 0.16 LA diameter (cm) 1.16 0.32 4.15 0.82 0.12 LAAT 1.57 0.50 4.93 0.44 0.1 Aspirin 2.00 0.39 10.3 0.41 0.09 LAVI (ml/ m2 ) 1.01 0.97 1.05 0.74 0.09 LVEF (%) 0.96 0.84 1.09 0.50 0.09 MRA 0.54 0.13 2.19 0.39 0.09 BMI (kg/m2) 1.00 0.89 1.13 0.94 0.08 E/e` 1.01 0.94 1.07 0.85 0.07 Global PACS (%) 1.13 0.71 1.79 0.62 0.07 E/A 1.11 0.68 1.84 0.67 0.06 Global PALS (%) 0.97 0.74 1.29 0.84 0.05 Beta-blocker 0.57 0.09 3.74 0.56 0.04 Digoxin 2.59 0.15 43.7 0.51 0.03 LA area (cm2 ) 0.99 0.92 1.07 0.83 0.03 Hypertension 1.09 0.37 3.28 0.87 0.02 Female sex 1.27 0.11 14.9 0.85 0.01 Other antiplatelet agent 0.93 0.22 3.97 0.92 0.01 Statin 0.95 0.31 2.93 0.93 0.01
Abbreviations as in Table 1 and Table 3
